N. Thorsgaard Pedersen

Incidence of Alcoholic Chronic Pancreatitis in Copenhagen

A retrospective study of 126 patients with chronic pancreatitis diagnosed from 1970 to 1979 is presented. The aim was to evaluate whether the incidence of chronic pancreatitis had increased and to present briefly the clinical aspects of chronic pancreatitis in Copenhagen. The annual incidence of chronic pancreatitis rose from 6.9 to 10.0 per 100,000 during the 10 years of the study. This increase was only due to an augmentation in the number of patients with alcoholic chronic pancreatitis. Clinical aspects of chronic pancreatitis were similar to those found in other European countries. The present study suggests that alcoholic chronic pancreatitis will be a commoner disease in Denmark in the future.

Chronic pancreatitis in Copenhagen. A retrospective study of 64 consecutive patients.

A longitudinal study of 64 patients with chronic pancreatitis is presented. The patients were followed up for a median period of 4 years. Pain was the dominant symptom in 43 of the patients, but only 5 patients had pancreatic resection because of pain. Alcoholism was the etiology in 45 patients. Complications were common: 34 patients developed steatorrhea and 29 diabetes. Two major groups of associated diseases contributed to a high morbidity in chronic pancreatitis: 24 patients presented with duodenal ulcer, and 8 developed malignant tumors. This number is significantly higher than expected in a matched population (P less than 0.01). Twenty-six of the patients died within the observation period from complications of chronic pancreatitis (38%), from malignant neoplasms (15%), or from other causes (46%). The calculated mortality rate after 7 years of observation was close to 50%. Most patients were recruited from the lower social classes, and most were unemployed. We conclude that chronic pancreatitis in Copenhagen is associated with a high morbidity, a high mortality, and a poor social prognosis.

B cell function in patients with chronic pancreatitis and its relation to exocrine pancreatic function

SummaryExocrine pancreatic function was evaluated by a Lundh meal test and a secretin-cholecystokinin test in 16 patients with chronic pancreatitis. B cell function was assessed by measuring the concentration of C-peptide after stimulation with oral glucose and intravenous glucagon. The C-peptide response to intravenous glucagon and oral glucose was closely correlated (r = 0.88,p < 0.01). Plasma C-peptide after glucagon was significantly correlated to the post-prandial concentration of lipase (r = 0.72,p < 0.001), amylase (r=0.64,p < 0.05) and to amylase output (r = 0.64,p < 0.05). Eight out of nine patients treated with insulin had residual B cell function, but it diminished significantly with increasing duration of diabetes. We conclude that B cell function is correlated to pancreatic enzyme secretion and that patients with insulin-treated diabetes secondary to chronic pancreatitis have a residual insulin secretion similar to that of patients with Type 1 (insulin-dependent) diabetes.

Autoantibodies in chronic pancreatitis.

In 60 consecutive patients clinically suspected of having chronic pancreatitis the serum concentration of the immunoglobulins (IgA, IgG, IgM), the IgG- and IgA-type non-organ-specific autoantibodies against nuclear material (ANA), smooth and striated muscle, mitochondria, basal membrane, and reticulin, and the IgG- and IgA-type pancreas-specific antibodies against islet cells, acinus cells, and ductal cells (DA) were estimated blindly. In 23 of the patients chronic pancreatitis was verified, whereas chronic pancreatitis was rejected in 37 patients (control group). IgG and IgA were found in significantly higher concentrations in the patients with chronic pancreatitis than in the control group but within the normal range. ANA and DA occurred very frequently in both groups but with no statistical difference. Other autoantibodies only occurred sporadically. The findings of this study do not support the view of an immunological pathogenesis in chronic pancreatitis.

Estimation of 14C-Triolein Assimilation as a Test of Lipid Assimilation: Breath Test or Measurement of Serum Radioactivity?

Two tests of lipid assimilation based on estimation of 14C-triolein assimilation from expiratory 14CO2 (breath test) and from serum radioactivity of 14C, respectively, were investigated in 48 consecutive patients suspected of having malassimilation. Patients with proven malassimilation had significantly lower expiration of 14CO2 and lower serum radioactivity of 14C than patients with normal lipid assimilation. The se-14C test correctly diagnosed significantly more patients with malassimilation than the breath test; the diagnostic efficiencies were 0.87 and 0.74, respectively. The results of both tests correlated with measurement of faecal fat. However, within the group of patients with proven malassimilation the results of the breath test correlated poorly with faecal fat, whereas a significant correlation was found between the se-14C test and faecal fat within this group. Correspondingly, the correlation between the results of the breath test and the se-14C test was poor, indicating that intermediate metabolism influences the results.

Short report: lipid and vitamin B12 malassimilation in pancreatic insufficiency

Patients with exocrine pancreatic insufficiency have steatorrhoea as well as vitamin B12 malassimilation. To investigate whether this is caused by the pancreatic insufficiency per se or whether intestinal bacterial overgrowth contributes to the condition, 10 patients with pancreatic steatorrhoea were studied. Intestinal culture was done. Lipid and vitamin B12 assimilation was estimated from faecal spot tests, using 14C‐triolein and 58Co‐vitamin B12 as tracers and 51CrCl3 as marker. Out of the 10 patients, 9 had either vitamin B12 malassimilation (n= 8), and/or bacterial overgrowth (n= 5). These 9 patients were retested with pancreatic enzyme therapy, with and without addition of the antibiotics metronidazole and cefalexin. The lipid assimilation was significantly increased by enzyme therapy but did not improve further on additional antibiotic treatment. The vitamin B12 assimilation did not improve significantly on enzyme therapy nor with additional antibiotic treatment.

Serum Cathodic Trypsin-like Immunoreactivity, Pancreatic Lipase, and Pancreatic Isoamylase as Diagnostic Tests of Chronic Pancreatitis or Pancreatic Steatorrhea

We compared serum concentrations of cathodic trypsin-like immunoreactivity, pancreatic lipase, and pancreatic isoamylase as diagnostic tests of chronic pancreatitis (and of pancreatic steatorrhea in the 41 patients with steatorrhea) in 105 patients (57 men, 48 women) consecutively investigated because of clinical suspicion of chronic pancreatitis. Chronic pancreatitis (36 patients), pancreatic steatorrhea (24 patients), and other diseases were diagnosed without knowledge of the serum levels of the three enzymes. When evaluated by means of receiver operating characteristic curves, no differences were found in diagnostic performance of the enzymes with regard to chronic pancreatitis or pancreatic steatorrhea. The sensitivity and specificity for recognition of chronic pancreatitis ranged from 0.306 to 0.444 and from 0.942 to 0.986 when the discrimination values were chosen to give highest efficiencies. The similar ranges for pancreatic steatorrhea were 0.500-0.708 and 0.882-0.941. In conclusion, none of the three enzymes had any advantage over the others as diagnostic tests of chronic pancreatitis or of pancreatic steatorrhea. Only positive test results have clinical importance because of the low sensitivities of the three enzymes.

Serum Radioactivity of 14C-Triolein and 3H-Oleic Acid Ingested in a Test Meal

A double-tracer technique to estimate lipid digestion was investigated. 3H-labelled oleic acid and 14C-labelled triolein were ingested in a test meal. The serum radioactivity of 3H after ingestion of labelled oleic acid depends on absorption and metabolism of free fatty acids, while serum radioactivity of 14C from triolein, in addition to the former, depends on triglycerol digestion. This study shows that the ratio between 3H and 14C 2h after the test meal gives a good qualitative and quantitative estimation of lipid digestion: the 3H/14C ratio in patients with maldigestion is significantly higher than for normals (P less than 0.01), the predictive value of the 3H/14C ratio in the diagnosis of maldigestion is high, that of a positive result being 1.0 and that of a negative 0.93, and quantitatively the 3H/14C ratio shows a highly significant correlation with faecal fat (P less than 0.001). The test is very easy to perform, lasts for only 2 h, and is without discomfort to the patient or nursing and laboratory staff. It gives information like or superior to that of faecal fat measurement.

Estimation of the 3-Day Faecal Fat Excretion and Fat Concentration as a Differential Test of Malabsorption and Maldigestion

The diagnostic efficiency of estimating the faecal fat excretion and faecal fat concentration in uncontrolled 3-day collections was estimated from a prospective series of 87 consecutive patients. The diagnoses were established on the basis of morphologic criteria, and the assimilation was established from the faecal 14C-triolein/3H-oleic acid test. These investigations showed the diagnostic sensitivity of the 3-day faecal fat excretion to be 90%. The 3-day mean faecal fat concentration was less than or equal to 5.1% w/w in patients with normal lipid assimilation. Of the patients with malassimilation 90% had a faecal fat concentration greater than or equal to 5.1% w/w. The faecal fat concentration was especially high in patients with maldigestion. When 10% w/w was used as the discrimination level between malabsorption and maldigestion, the faecal fat concentration correctly distinguished between these in 66% of the patients with malassimilation. The day-to-day variation of the faecal fat concentration was modest. Diagnosis of the lipid assimilation as estimated by the 1-day faecal fat concentration agreed with the diagnosis of the mean 3-day faecal fat concentration in 115 of the 122 1-day samples. The 1-day faecal fat concentration seems useful as a first screening test when malassimilation is suspected.

The Serum 14C-Triolein/3H-01eic Acid Assimilation Test for Differential Diagnosis of Maldigestion and Malabsorption

In 125 consecutive patients the measurement of serum radioactivities after simultaneous ingestion of 14C-triolein and 3H-oleic acid was investigated as a test of lipid assimilation. The sum of the 2-h and 4-h concentrations of 14C in serum (se(2 + 4)14C) was most useful as an index of lipid assimilation, and the 2-h serum 3H/14C ratio (se-3H/14C) reflected lipid digestion. Normal values were se(2 + 4)14C ≥ 1.0% of the dose ingested per litre serum and se-3H/14C 7 g/day. False-negative values appeared mainly in the patients with moderate steatorrhoea and gastrointestinal anastomoses. Only one false-positive se(2 + 4)14C value was found. Se-3H/14C was abnormal in 24 of the 34 patients with maldigestion with 2 false-positive results. When the results of se(2 + 4)14C and se-3H/14C were combined, the predictive value of the test result ‘normal l...